隨著科技快速發展，數位轉型已成為企業提升營運效率與維持競爭力的重要途徑。製藥產業具有高度法規要求、產品安全責任重大及供應鏈關係複雜等特性，從原料採購、生產製造、倉儲配送至最終使用者，涉及多元利害關係人與跨組織協作。因此，如何提升供應鏈資訊的透明度、產品流向的可追溯性，以及各參與者之間的協作效率，已成為製藥產業推動數位轉型時的重要課題。藥廠在供應鏈實務運作上仍面臨許多挑戰，包括上下游資訊不對稱、企業間資訊系統異質、跨組織資料共享不易、原料交期不確定，以及產品於運輸與流通過程中可能遭受偽造或非法竄改等問題。這些問題不僅可能影響供應鏈的穩定性與營運效率，也可能對藥品品質、產品安全及消費者信任造成威脅。若供應鏈交易與物流資訊能夠更有效地整合與驗證，除有助於改善供應鏈管理與產品追溯，也可進一步提升交易資料的可信度，並為後續供應鏈金融等延伸應用提供發展基礎。
本研究以台灣藥廠供應鏈為場域，透過半結構式訪談四位具製藥供應鏈與區塊鏈相關實務經驗之受訪者，探討區塊鏈技術導入之可行性與可能效益，聚焦於其導入台灣藥廠供應鏈時，在資料與系統可行性、制度與法規可行性、組織與治理可行性，以及經濟與資源可行性四個面向的執行條件與限制。
綜合訪談結果顯示，台灣藥廠供應鏈目前主要問題並非單一物流延遲，而是跨企業資訊不透明、ERP 系統高度異質、紀錄可信度不足以及國外原料交期不確定等結構性缺陷。若將區塊鏈定位為附加於既有系統之上的共同存證與稽核軌跡工具，而非全面取代現有 ERP 或作業流程，其在資料與系統條件上具有一定可行性，並可在供應商互信與官方稽核場域中最直接地展現「不可竄改、可追溯」之核心價值。
受訪者普遍認為，區塊鏈導入之實務可行性仍高度依賴法規基礎、治理模式設計、成本分攤機制與企業資訊開放意願等制度條件，真正的障礙主要來自「誰來主導」「誰來承擔責任」與「資料如何共享」等問題，而非技術本身是否成熟。 因此，本研究認為，區塊鏈在台灣藥廠供應鏈中的應用較適合採取「聚焦稽核與追溯、分階段導入、由主管機關或核心企業主導、高風險與高查核需求角色優先落地」之策略，以作為未來制度設計與試點推動的參考方向。

This study assesses the feasibility of implementing blockchain technology in the supply chains of Taiwanese pharmaceutical manufacturers, with a focus on practical implementation conditions rather than technical performance. It examines the major challenges faced by pharmaceutical supply chains and evaluates feasibility from four dimensions: data and system integration, institutional and regulatory compliance, organizational governance, and economic and resource requirements. A qualitative research design was adopted. Data were collected through semi-structured interviews with four professionals who had practical experience in pharmaceutical supply chains and blockchain-related applications. The interview data were transcribed, anonymized, coded, categorized, and compared across participants using thematic analysis.
The findings indicate that the primary challenges in Taiwan’s pharmaceutical supply chains. are cross-organizational information opacity, heterogeneous enterprise resource planning systems, insufficient reliability of operational records, and uncertainty surrounding the delivery of imported raw materials. Blockchain implementation is considered conditionally feasible when used as an additional shared recordkeeping and audit-trail mechanism rather than as a replacement for existing systems. However, practical implementation depends largely on regulatory recognition, governance arrangements, responsibility allocation, cost-sharing mechanisms, and the willingness of participating organizations to share information. The study concludes that blockchain adoption should proceed incrementally, prioritize high-risk and audit-intensive processes such as traceability and quality records, and be led or supported by a regulatory authority, a core enterprise, or an industry alliance. Its successful implementation requires institutional and organizational coordination more than technological advancement alone.

Agbo, C. C., Mahmoud, Q. H., & Eklund, J. M. (2019). Blockchain technology in healthcare: A systematic review. Healthcare, 7(2), 56.
Alison, L. (2020). Blockchain and its impact on pharmaceutical supply chain security. International Journal of Pharmaceutical Sciences, 12(3), 45–50.
Atzei, N., Bartoletti, M., & Cimoli, T. (2017). A survey of attacks on Ethereum smart contracts (SoK). In International Conference on Principles of Security and Trust (pp. 164–186). Springer.
Bodkhe, U., Tanwar, S., Parekh, K., Khan, R., Tyagi, S., Kumar, N., & Alazab, M. (2020). Blockchain for industry 4.0: A comprehensive review. IEEE Access, 8, 79764–79800. https://doi.org/10.1109/ACCESS.2020.2988579
Burniske, C., Vaughn, J., Cahana, A., & Shelton, M. (2016). Blockchain: Blueprint for a new economy. O'Reilly Media.
Buterin, V. (2014). A next-generation smart contract and decentralized application platform. Retrieved from https://ethereum.org/en/whitepaper/
Casino, F., Dasaklis, T. K., & Patsakis, C. (2019). A systematic literature review of blockchain-based applications: Current status, classification and open issues. Telematics and Informatics, 36, 55–81. https://doi.org/10.1016/j.tele.2018.11.006
Castro, M., & Liskov, B. (1999). Practical Byzantine fault tolerance. Proceedings of the Third Symposium on Operating Systems Design and Implementation, 173–186. https://doi.org/10.1145/296806.296824
Chen, L., Xu, L., Lu, Y., & Chen, J. (2020). Exploring blockchain technology and its potential applications for education. Smart Learning Environments, 7(1), 1–14. https://doi.org/10.1186/s40561-020-00134-x
Chen, Y. (2020). Smart contracts and the future of blockchain. Journal of Emerging Technologies, 8(3), 21–30.
Chen, Y. C., Lin, Z. Y., & Chang, C. H. (2020). Blockchain in SMEs' supply chains: Implementation barriers and solutions in Taiwan. Journal of Enterprise Information Management, 33(6), 1301–1320.
Chen, Y. H., & Lin, C. W. (2024). 藥廠數據完整性符合性現況分析 [Analysis of data integrity compliance in pharmaceutical manufacturers]. Taiwan Journal of Public Health, 43(6), 30–45. https://www.airitilibrary.com/Article/Detail/22195718-N202501110023-00030
CSCMP. (2013). Supply Chain Management Definitions and Glossary of Terms. Council of Supply Chain Management Professionals.
Ding, B. (2018). Pharmaceutical supply chain transformation enabled by industry 4.0 technologies. Journal of Industrial Integration and Management, 3(03), 1850015.
Ding, H. (2018). Blockchain-based pharmaceutical supply chain integrity verification. Journal of the Society for Information Display, 26(5), 252–258. https://doi.org/10.1002/jsid.666
Dreyfuss, G. (2020). Blockchain applications in healthcare logistics: Challenges and solutions. Journal of Medical Systems, 44(5), 101–115.
DuHadway, S., & Carnovale, S. (2019). Disrupting the supply chain: The impact of supplier failure and buyer learning. International Journal of Operations & Production Management, 39(1), 96–119.
DuHadway, S., & Carnovale, S. (2019). Weak ties and supply chain disruption propagation. Journal of Supply Chain Management, 55(2), 27–41. https://doi.org/10.1111/jscm.12187
DuHadway, S., & Carnovale, S. (2019). Weak ties and supply chain disruption propagation. Journal of Supply Chain Management, 55(2), 27–41. https://doi.org/10.1111/jscm.12187
Francisco, K., & Swanson, D. (2018). The supply chain has no clothes: Technology adoption of blockchain for supply chain transparency. Logistics, 2(1), 2. https://doi.org/10.3390/logistics2010002
Gelsomino, L. M., Mangiaracina, R., Perego, A., & Tumino, A. (2016). Supply chain finance: A literature review. International Journal of Physical Distribution & Logistics Management, 46(4), 348–366.
Gunasekaran, A., Subramanian, N., & Papadopoulos, T. (2020). Modeling the blockchain enabled traceability in agriculture supply chain. International Journal of Production Research. https://doi.org/10.1080/00207543.2019.1684694
Hsu, L. C., & Chen, Y. T. (2023). A comparative analysis of Taiwan's pharmaceutical track and trace system. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.4628315
Iansiti, M., & Lakhani, K. R. (2017). The truth about blockchain. Harvard Business Review, 95(1), 118–127.
IQVIA. (2025). Navigating DSCSA compliance in the pharmaceutical industry. Durham, NC: IQVIA Institute.
Jaberidoost, M., Mousavi, S. M., & Zarei, M. (2013). Risk management in pharmaceutical supply chains. International Journal of Pharmaceutical Sciences, 8(1), 34–40.
Julien, G., & Stienon, A. (2025). China’s active pharmaceuti cal ingredient (API) manufacturing system: The security and political risks of U.S. dependence for supplies of essential drugs. Paris, France: Institut Montaigne.
Kamble, S. S., Gunasekaran, A., & Sharma, R. (2023). The benefits and challenges of blockchain in healthcare supply chain management. Cureus, 17(9), e69184. https://doi.org/10.7759/cureus.69184
Khan, S. N., Loukil, F., Ghedira-Guegan, C., Benkhelifa, E., & Bani-Hani, A. (2023). Supply chain management of drug products in blockchain using smart contracts. International Journal of Technology, 14(7), 6626. https://ijtech.eng.ui.ac.id/article/view/6626
KPMG. (2022). Industrial Internet of Things (IIoT) White Paper.
Kshetri, N. (2018). Blockchain’s roles in meeting key supply chain management objectives. International Journal of Information Management, 39, 80–89. https://doi.org/10.1016/j.ijinfomgt.2017.12.005
LedgerDomain. (2020, September 22). Answering the FDA's call: LedgerDomain's Hyperledger Fabric-based BRUINchain. https://www.lfdecentralizedtrust.org/blog/2020/09/22/answering-the-fdas-call-ledgerdomains-hyperledger-fabric-based-bruinchain-i
Lee, J., Kumar, S., & Singh, R. (2022). Blockchain technology in pharmaceutical supply chains: A transaction cost perspective. Management & Sustainability: Current Research and Future Directions, 10(4), 215–230. https://doi.org/10.1108/mscra-10-2022-0023
Mackey, T. K., & Nayyar, G. (2016). A review of existing and emerging digital technologies to combat the global trade in fake medicines. Expert Opinion on Drug Safety, 15(5), 681–694. https://doi.org/10.1517/14740338.2016.1165660
McCauley, D. (2020). Securing the pharma supply chain with cryptographic identity verification. Healthcare Technology Letters, 7(4), 98–103.
Mohana, A., Ong, T. S., & Ern, L. P. (2019). Exploring the application of blockchain in pharmaceutical supply chain. International Journal of Academic Research in Business and Social Sciences, 9(2), 1031–1044.
Mohana, M., et al. (2019). "Implementation of pharmaceutical drug traceability using blockchain technology." Inti Journal 2019(35).
Mohana, R., Ong, S., & Kumar, P. (2019). Temperature-controlled pharmaceutical supply chains: An evaluation of risk factors. Journal of Pharmaceutical Sciences, 105(4), 1072–1085.
Nakamoto, S. (2008). Bitcoin: A peer-to-peer electronic cash system. https://bitcoin.org/bitcoin.pdf
National Development Council. (2024). [臺灣區塊鏈政策報告].
Nguyen, Q. K., Wang, X., & Zhang, Y. (2022). Blockchain and supply chain finance: A critical literature review at the intersection of operations, finance and law. Journal of Banking and Financial Technology, 6(2), 123–139. https://doi.org/10.1007/s42786-022-00040-1
Nizamuddin, N., & Abdallah, S. (2023). Blockchain-based solution for pharma supply chain industry. Computers & Industrial Engineering, 177, 108997. https://doi.org/10.1016/j.cie.2023.108997
Nizamuddin, N., & Abdallah, S. (2023). Blockchain-based solution for pharma supply chain industry. Computers & Industrial Engineering, 177, 108997. https://doi.org/10.1016/j.cie.2023.108997
Panda, S. K., Satapathy, S. C., & Mohapatra, D. P. (2023). Assessment of implementation barriers of blockchain technology in developing countries' public health systems. BMC Medical Informatics and Decision Making, 23(1), 95. https://doi.org/10.1186/s12911-023-02192-x
Peron, M., Saporiti, N., Pozzi, R., & Ciano, M. P. (2025). Blockchain in the pharmaceutical sector: Empirical evidence on the associated challenges and countermeasures. International Journal of Production Economics, 288, Article 109685. https://doi.org/10.1016/j.ijpe.2025.109685
PwC Taiwan. (2022). [臺灣區塊鏈SMEs報告].
Reshma. (2023). A blockchain-based approach for drug traceability in healthcare supply chain. International Journal for Research in Applied Science and Engineering Technology, 11(12). https://doi.org/10.22214/ijraset.2023.55609
Shashi, K., & Gossett, M. (2022). Blockchain in supply chain management: A comprehensive analysis. Journal of Supply Chain Technology, 45(2), 58–72.
Singh, R., Dwivedi, Y. K., Rana, N. P., & Kumar, A. (2025). Blockchain in the pharmaceutical sector: Empirical investigation of barriers and facilitators. International Journal of Production Economics, 281, 109713. https://doi.org/10.1016/j.ijpe.2025.109713
Swan, M. (2015). Blockchain: Blueprint for a new economy. O’Reilly Media.
Szabo, N. (1997). Formalizing and securing relationships on public networks. First Monday, 2(9). https://doi.org/10.5210/fm.v2i9.548
Taiwan Blockchain Alliance. (2023). Taiwan blockchain industry report 2023. Taipei, Taiwan.
Taiwan Food and Drug Administration. (2016, August 1). 確保民眾用藥安全，西藥廠應落實數據完整性(data integrity) [Ensuring drug safety: Pharmaceutical manufacturers should implement data integrity]. https://www.fda.gov.tw/TC/lawContent.aspx?id=2840
Taiwan Food and Drug Administration. (2017, July 5). TFDA launches track and trace system for medicinal products. https://www.fda.gov.tw/eng/newsContent.aspx?id=22244
Taiwan Food and Drug Administration. (2018, November 22). 基於「數據完整性(Data Integrity)」為當前製藥產業落實GMP之基礎 [Data integrity as the foundation of GMP implementation in the pharmaceutical industry]. https://www.fda.gov.tw/TC/lawContent.aspx?scid=180&pn=5&id=3073
Taiwan Food and Drug Administration. (2019). 藥品優良製造規範-數據管理及完整性作業指引 [Pharmaceutical good manufacturing practice - Guidelines for data management and integrity]. https://tcmia.org.tw/upload/fckimages/file/108.08.06_20190820_1.pdf
Taiwan Food and Drug Administration. (2025, September 1). GMP standards and regulatory oversight of Taiwan's pharmaceutical manufacturers. https://www.fda.gov.tw/eng/newsContent.aspx?id=31195
U.S. FDA. (2023). Blockchain interoperability pilot project report. https://www.fda.gov/media/169883/download
U.S. Pharmacopeia. (2025). Global medicines supply map: Dependence on overseas APIs and key starting materials. Rockville, MD: U.S. Pharmacopeial Convention.
U.S.-China Economic and Security Review Commission. (2025). Chained to China: Beijing’s weaponization of supply chains (Annual Report, Chapter 9). Washington, DC: U.S. Government Publishing Office.
Verhoef, P. C., Broekhuizen, T., Bart, Y., Bhattacharya, A., Dong, J. Q., Fabian, N., & Haenlein, M. (2021). Digital transformation: A multidisciplinary reflection and research agenda. Journal of Business Research, 122, 889–901. https://doi.org/10.1016/j.jbusres.2019.09.022
Wang, H., Li, X., & Chen, T. (2024). Blockchain-based supply chain finance: A systematic review and future research directions. Sustainability, 16(7), 2823. https://doi.org/10.3390/su16072823
Wang, S., Ouyang, L., Yuan, Y., Ni, X., Han, X., & Wang, F. Y. (2019). Blockchain-enabled smart contracts: Architecture, applications, and future trends. IEEE Transactions on Systems, Man, and Cybernetics: Systems, 49(11), 2266–2277.
Weking, J., Stöcker, M., Kowalkiewicz, M., Böhm, M., & Krcmar, H. (2020). Leveraging industry 4.0—A business model pattern framework. International Journal of Production Economics, 225, 107588.
Wuttke, D. A., Blome, C., Heese, H. S., & Wieland, A. (2013). Supply chain finance: Optimal introduction and adoption decisions. International Journal of Production Economics, 145(2), 573–586. https://doi.org/10.1016/j.ijpe.2013.05.027
Yang, C. Y. (2023, February 13). Pharmaceutical track and trace lecture series. National Yang Ming Chiao Tung University Digital Law Center. https://digital.law.nycu.edu.tw/blog-post/zlfmfk/
Yli-Huumo, J., Ko, D., Choi, S., Park, S., & Smolander, K. (2016). Where is current research on blockchain technology?—A systematic review. PloS One, 11(10), e0163477. https://doi.org/10.1371/journal.pone.0163477
Yoo, S., & Won, D. (2018). The impact of blockchain on supply chain: A theory-based research framework and a call for research. Journal of Industrial Engineering and Management, 11(4), 845–858. https://doi.org/10.3926/jiem.2635
Zhang, L., & Patel, M. (2024). Secure pharmaceutical supply chain using blockchain in IoT cloud systems. Internet of Things and Cyber-Physical Systems, 4(1), 45–60. https://doi.org/10.1016/j.iotcps.2024.100156
Zhang, Y., Li, X., & Kumar, A. (2024). Secure pharmaceutical supply chain using blockchain in IoT cloud environment. Journal of Industrial Information Integration, 35, 100495. https://doi.org/10.1016/j.iot.2024.101215.
Zhong, R. Y., Xu, X., Klotz, E., & Newman, S. T. (2017). Intelligent manufacturing in the context of industry 4.0: A review. Engineering, 3(5), 616–630. https://doi.org/10.1016/J.ENG.2017.05.015
Zhou, L., Shamsuzzoha, A., & Harris, I. (2023). Data-driven review of blockchain applications in supply chain management. International Journal of Production Research. Advance online publication. https://doi.org/10.1080/00207543.2023.2165190
Zhou, W., Sun, C., Wang, X., & Wang, L. (2020). Integration of industry 4.0 technologies and blockchain for supply chain transparency: Architecture and case study. Computers & Industrial Engineering, 147, 106668.
中國工商銀行（2020）。《區塊鏈白皮書》。
中國信通院 & 京東金融研究院（2018）。《區塊鏈技術與應用白皮書》。
王毅丞（2018）。區塊鏈應用於供應鏈之研究：以製藥產業為例。《中山管理評論》，26(2)，183–212。
周濟群（2016）。區塊鏈與供應鏈金融創新應用之探討。《資訊科技與應用學刊》，7(1)，45–53。
張凱君（2022）。《區塊鏈與供應鏈金融之研究》。國立政治大學科技管理研究所碩士論文。
衛福部. (2019). 藥品生產與數據完整性管理原則。衛生福利部食品藥物管理署。
臺北醫學大學附設醫院。（2018年8月30日）。區塊鏈比你想像得更貼近生活：北醫附醫啟動健康醫療區塊鏈平台。https://www.tmuh.org.tw/single/3780
衛生福利部。（2018年8月30日）。北醫附醫分級醫療暨區塊鏈啟動病歷共享區域共照醫病共好。https://www.mohw.gov.tw/cp-16-43622-1.html
林業及自然保育署。（2019年12月5日）。臺灣木竹材將有身分證了：全球首創應用區塊鏈的林產品追溯系統正式上線。https://www.forest.gov.tw/0000013/0064945